Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$5.4 million.

  • Onconetix's Other Non Operating Income fell 1206923.4% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.3 million, marking a year-over-year decrease of 1271759.72%. This contributed to the annual value of $168746.0 for FY2024, which is 13443.8% up from last year.
  • Onconetix's Other Non Operating Income amounted to -$5.4 million in Q3 2025, which was down 1206923.4% from -$22660.0 recorded in Q2 2025.
  • Onconetix's 5-year Other Non Operating Income high stood at $126852.0 for Q4 2024, and its period low was -$5.4 million during Q3 2025.
  • Moreover, its 3-year median value for Other Non Operating Income was -$14011.5 (2025), whereas its average is -$594805.2.
  • As far as peak fluctuations go, Onconetix's Other Non Operating Income skyrocketed by 166513.93% in 2024, and later plummeted by 1206923.4% in 2025.
  • Onconetix's Other Non Operating Income (Quarter) stood at -$490000.0 in 2023, then soared by 125.89% to $126852.0 in 2024, then plummeted by 4344.88% to -$5.4 million in 2025.
  • Its Other Non Operating Income stands at -$5.4 million for Q3 2025, versus -$22660.0 for Q2 2025 and -$5363.0 for Q1 2025.